Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Slide 1
Document related concepts
no text concepts found
Transcript
Genomics Commercialization Glen Schuler Managing Director, Industry Liaison Office University of Saskatchewan Genomics Commercialization: Drug Timeline 30% The Canadian Biopharmaceutical Industry Technology Roadmap R&D Drug Investment by Function Stage Discovery Preclinical Phase I Phase II Phase III Regulatory Approval Phase IV (Post Marketing) Uncategorized Percentage 25 7 7 11 23 12 11 4 Drug discovery = 25% of R&D costs and 45% of development time. Tools such as genomics, bioinformatics, etc. have had minimal impact on R&D productivity when measured by the number of drugs that have entered clinical trials and moved to regulatory approval. Pharmaceutical Research and Manufacturers of America, Annual Membership Survey, 2003 Genomics Commercialization Genomics Commercialization Glen Schuler Managing Director, Industry Liaison Office University of Saskatchewan
